Literature DB >> 19346699

Both type-I and type-II responses contribute to murine trypanotolerance.

Boniface Namangala1, Patrick De Baetselier, Alain Beschin.   

Abstract

The host immune system has been documented to influence the course and outcome of infection with the phospholipase-C-deficient (PLC(-/-)) Trypanosoma brucei brucei. We addressed the resistant mechanisms during trypanosomosis by comparing the immune response to variant-specific surface glycoprotein (VSG) in relatively susceptible C3H mice and trypanotolerant (C57BL/6 x BALB/c)-F1 (B6B-F1) mice infected with PLC(-/-) parasites. During the early stage of infection, lymphoid cells from both PLC(-/-)-susceptible C3H and -tolerant B6B-F1 mice mainly secreted VSG-specific IFN-gamma. Although C3H mice remained locked in a type-I cytokine environment (IFN-gamma, TNF-alpha) during late stage of infection, B6B-F1 mice switched to production of type-II cytokines (IL-4, IL-10) from late stage of infection onwards. It seems that VSG-specific cytokine responses associated with resistance to murine African trypanosomosis are infection-stage dependent, with type-I cytokine responses being critical during the early stage of infection while type-II cytokine responses appear to be more important during the late and chronic phases of the disease. Because of the striking similarities in the course of the PLC(-/-)infection in B6B-F1 mice with that of the trypanotolerant N'dama cattle naturally-infected with T. congolense, the PLC(-/-)-infected B6B-F1 mice represents a suitable model to study the course of infection and immune responses during bovine trypanosomosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19346699     DOI: 10.1292/jvms.71.313

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  9 in total

1.  Immunobiology of African trypanosomes: need of alternative interventions.

Authors:  Toya Nath Baral
Journal:  J Biomed Biotechnol       Date:  2010-02-23

2.  Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection.

Authors:  Liam J Morrison; Sarah McLellan; Lindsay Sweeney; Chi N Chan; Annette MacLeod; Andy Tait; C Michael R Turner
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 3.  Human host determinants influencing the outcome of Trypanosoma brucei gambiense infections.

Authors:  B Bucheton; A MacLeod; V Jamonneau
Journal:  Parasite Immunol       Date:  2011-08       Impact factor: 2.280

Review 4.  African Trypanosomiasis-Associated Anemia: The Contribution of the Interplay between Parasites and the Mononuclear Phagocyte System.

Authors:  Benoit Stijlemans; Patrick De Baetselier; Stefan Magez; Jo A Van Ginderachter; Carl De Trez
Journal:  Front Immunol       Date:  2018-02-15       Impact factor: 7.561

Review 5.  To the Skin and Beyond: The Immune Response to African Trypanosomes as They Enter and Exit the Vertebrate Host.

Authors:  Omar A Alfituri; Juan F Quintana; Annette MacLeod; Paul Garside; Robert A Benson; James M Brewer; Neil A Mabbott; Liam J Morrison; Paul Capewell
Journal:  Front Immunol       Date:  2020-06-12       Impact factor: 7.561

6.  Plasma cytokine profiles associated with rhodesiense sleeping sickness and falciparum malaria co-infection in North Eastern Uganda.

Authors:  Julius Nsubuga; Charles Drago Kato; Ann Nanteza; Enock Matovu; Vincent Pius Alibu
Journal:  Allergy Asthma Clin Immunol       Date:  2019-10-30       Impact factor: 3.406

7.  Plasma cytokines quantification among Trypanosoma brucei rhodesiense sleeping sickness cases and controls in Rumphi, Malawi.

Authors:  Kelita Kamoto; Arthur Chiwaya; Peter Nambala; Pricilla Chammudzi; Edward Senga; John Chisi; Enock Matovu; Janelisa Musaya
Journal:  Malawi Med J       Date:  2021-12       Impact factor: 0.875

Review 8.  The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.

Authors:  Charles D Kato; Enock Matovu; Claire M Mugasa; Ann Nanteza; Vincent P Alibu
Journal:  Allergy Asthma Clin Immunol       Date:  2016-01-22       Impact factor: 3.406

Review 9.  Host Immune Responses and Immune Evasion Strategies in African Trypanosomiasis.

Authors:  Chukwunonso Onyilagha; Jude Ezeh Uzonna
Journal:  Front Immunol       Date:  2019-11-22       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.